Culig and colleagues demonstrated that, in human prostate cancer cells, various growth factors including insulin-like growth factor 1 (IGF-I), keratinocyte growth factor (KGF), and epidermal growth factor (EGF) directly activate the AR in the absence of androgens [91]. Here, IGF1 is linked to prostate carcinoma.